From muddying the waters on vaccine policy to espousing MAHA, Kennedy’s first month in office offers a glimpse into the next four years of public health.

One of the most underappreciated applications of artificial intelligence in the corporate world involves its role in writing ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Wealthfront Advisers LLC lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 84.4% during the fourth quarter, according to the company in its most recent disclosure with the ...

But these antics actually do serve a useful social and political purpose — for Trump’s fellow deep pockets and the ...

Paula Newton speaks with co-founder and Chair of Moderna, Noubar Afeyan, about his hopes for the release of Ruben Vardanyan, ...

Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

In early 2021, individual investors and institutions hurled money at Moderna stock as if future growth were unlimited.

COVID-19 vaccination in early pregnancy (≤20 weeks of gestation) is not associated with increased prevalence of major ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.